Hypertension Journal

Register      Login

VOLUME 1 , ISSUE 1 ( July-September, 2015 ) > List of Articles


Stroke and Hypertension: Recent Trends of High Blood Pressure and the Decline in Stroke Mortality

Daniel T Lackland

Keywords : Blood pressure,Disease risks,Hypertension,Population,Stroke

Citation Information : Lackland DT. Stroke and Hypertension: Recent Trends of High Blood Pressure and the Decline in Stroke Mortality. Hypertens J 2015; 1 (1):22-27.

DOI: 10.5005/jp-journals-10043-0004

Published Online: 01-06-2016

Copyright Statement:  Copyright © 2015; The Author(s).


How to cite this article

Lackland DT. Stroke and Hypertension: Recent Trends of High Blood Pressure and the Decline in Stroke Mortality. Hypertens J 2015;1(1):22-27.

PDF Share
  1. Factors influencing the decline in stroke mortality. Stroke 2014;45:315-353.
  2. Epidemiology and prevention of stroke, now and in the future. Epidemiol Rev 2000;22:14-17.
  3. Risk factors for ischemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTRokE study): a case-control study. Lancet 2010;376:112-123.
  4. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
  5. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
  6. Vital signs: prevalence, treatment, and control of hypertension-United States, 1999 to 2002 and 2005 to 2008. MMWR Morb Mortal Wkly Rep 2011;60:103-108.
  7. The World Health Report 2002: Reducing risks, promoting healthy life. Geneva, Switzerland. Available at: http://www.who.int/whr/2002/. Accessed on: July 23, 2012.
  8. Arch Intern Med 1997;157:2413-2446.
  9. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-69.
  10. The National High Blood Pressure Education Program. Hypertension: A Companion to Brenner and Rector's The kidney. 2nd edition. In: oparil S, Weber M, editors. Philadelphia, PA: Elsevier Saunders; 2005.
  11. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001 to 2008. National health statistics reports; no 35. Hyattsville, MD: National Center for Health Statistics; 2011.
  12. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999 to 2008. NCHS Data Brief, no. 48. Hyattsville, MD: National Center for Health Statistics; 2010.
  13. Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994. Ann Epidemiol 2001;11:271-279.
  14. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
  15. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997;96:308-315.
  16. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002;287:1003-1010.
  17. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010;121:586-613.
  18. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682-1686.
  19. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995;13:915-924.
  20. Hypertension and the brain. The National High Blood Pressure Education Program. Arch Intern Med 1992;152:938-945.
  21. Hypertension in African-Americans. Circulation 1991;83:1465-1467.
  22. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med 1992;327:776-781.
  23. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension 1996;27:144-147.
  24. Severely increased blood pressure in the emergency department. Ann Emerg Med 2003;41:513-529.
  25. outcomes of black and white hypertensive individuals after 30 years of follow-up. Clin Exp Hypertens 1995;17:1091-1105.
  26. Comparison of cardiovascular risk factors for high brachial pulse pressure in blacks versus whites (Charleston Heart Study, Evans County Study, NHANES I and II Studies). Am J Cardiol 2008;102:1514-1517.
  27. Birth cohort evidence of population influences on blood pressure in the United States, 1887-1994. Ann Epidemiol 2001;11:271-279.
  28. Blood pressure control and risk of stroke: a population-based prospective cohort study. Stroke 2005;36:725-730.
  29. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000;356:1955-1964.
  30. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000;35:539-543.
  31. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA 1997;278:212-216.
  32. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 1991; 265:3255-3264.
  33. Predicting cardiovascular riskusing conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999;282:539-546.
  34. Baseline characteristics and early blood pressure control in the CoNVINCE Trial. Hypertension 2001;37:12-18.
  35. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002;4:393-404.
  36. Thirty-year survival for black and white hypertensive individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program. J Am Soc Hypertens 2008;2:448-454.
  37. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial. JAMA 1996;276:785791.
  38. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. Ann Intern Med 2003;139:169177.
  39. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Lancet 2000;356:359365.
  40. Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol 2004;43:1047-1055.
  41. The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hyper-trophy. The LIFE study. J Clin Hypertens (Greenwich) 2005; 7:152-158.
  42. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:1004-1010.
  43. outcomes with nifedipine GITS or Coamilozide in hypertensive diabetics and nondiabetics in intervention as a goal in hypertension (INSIGHT). Hypertension 2003;41:431-436.
  44. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a rando-mised, open-label, blinded endpoint morbidity and mortality study. Lancet 2007;369:1431-1439.
  45. Losartan benefits over atenolol in nonsmoking hypertensive patients with left ventricular hypertrophy: the LIFE study. Blood Press 2004;13:376-384.
  46. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke 2005;36:1218-1226.
  47. The Study on cognition and Prognosis in the Elderly (SCoPE)-major CV events and stroke in subgroups of patients. Blood Press 2005;14:31-37.
  48. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol 2010;56:77-85.
  49. Clinical outcomes in the diabetes cohort of the International verapamil SR-Trando-lapril study. Hypertension 2004;44:637-642.
  50. The Dutch TIA Trial Study Group. N Engl J Med 1991;325:1261-1266.
  51. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet 2013;382:507-515.
  52. gov. Systolic Blood Pressure Intervention Trial (SPRINT). Available at: http://www.clinicaltrials.gov/ct2/show/NCT01206062?term=SPRINT=3.AccessedApril8, 2013.
  53. A cooperative study. JAMA 1977;237:255-261.
  54. Arch Intern Med 1980;140:1280-1285.
  55. Arch Intern Med 1988;148:1023-1038.
  56. Arch Intern Med 1984;144:1045-1057.
  57. Arch Intern Med 1993;153:154-183.
  58. Translation of hypertension treatment guidelines into practice: a review of implementation. J Am Soc Hypertens 2011;5:197-207.
  59. Evidencebased guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-520.
  60. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich) 2014; 16:14-26.
  61. ESH/ESC guidelines for the management of arterial hypertension. Eur Heart J 2013;34:2159-2219.
  62. Implications of new hypertension guidelines in the United States. Hypertension 2012;60:639-644.
  63. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002;288:1882-1888.
  64. How far should salt intake be reduced? Hypertension 2003;42:1093-1099.
  65. Progress in the battle against hypertension. Changes in blood pressure levels in the United States from 1960 to 1980. Hypertension 1987;10:226-233.
  66. Implications of the INTERSALT study. Hypertension 1991;17(Suppl 1):I16-I20.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.